Activation of Akt leading to NF-κB up-regulation in chondrocytes stimulated with fbronectin fragment

Biomedical Research

Volumn 32, Issue 3, 2011, Pages 209-215

  Yasuda, Tadashi ^a  

^a TENRI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CARBOXY TERMINAL HEPARIN BINDING FIBRONECTIN FRAGMENT; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ARTICLE; CARTILAGE CELL; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MONOLAYER CULTURE; OSTEOARTHRITIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANTIGENS, CD44; CELLS, CULTURED; CHONDROCYTES; CHROMONES; FIBRONECTINS; HUMANS; HYALURONIC ACID; MORPHOLINES; NITRIC OXIDE; PEPTIDE FRAGMENTS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; UP-REGULATION;

EID: 79959813654     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.32.209     Document Type: Article

References (48)

1. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, and Hochberg M. (1986) Development of criteria for the classifcation and reporting of osteoarthritis: classifcation of osteoarthritis of the knee. Arthritis Rheum 29, 1039-1049.
2. Baldwin A.S. Jr. (1996). The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14, 649-683.
3. Bellacosa A, Testa J.R, Staal S.P, and Tsichlis P.N. (1991). A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254, 274-277.
4. Brown K, Claudio E, and Siebenlist U. (2003). NF-κB. In: Targeted Therapies in Rheumatology (Smolen JS and Lipsky PE, eds.), pp381-401, Martin Dunitz, London.
5. Chu S.C, Marks-Konczalik J, Wu H.P, Banks T.C, and Moss J. (1998). Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem Biophys Res Commun 248, 871-878.
6. Coffer P.J, and Woodget J.R. (1991) Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. Eur J Biochem 201, 475-481.
7. Downward J. (1998). Ras signalling and apoptosis. Curr Opin Genet Dev 8, 49-54.
8. Downward J. (1998). Lipid-regulated kinases: some common themes at last. Science 279, 673-674.
9. Finco T.S, and Baldwin A.S. Jr, (1995). Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3, 263-272.
10. Franke T.F, Kaplan D.R, and Cantley L.C, (1997). PI3K: downstream AKTion blocks apoptosis. Cell 88, 435-437.
11. Fruman D.A, Meyers R.E, and Cantley L.C. (1998). Phos-phoinositide kinases. Annu Rev Biochem 67, 481-507.
12. Hawkins P.T, Welch H, McGregor A, Eguinoa A, Gobert S, Krugmann S, Anderson K, Stokoe D, and Stephens L. (1997). Signalling via phosphoinositide 3OH kinases. Biochem Soc Trans 25, 1147-1151.
13. Homandberg G.A, Costa V, Ummadi V, and Pichika R. (2002). Antisense oligonucleotides to the integrin receptor subunit α5 decrease fbronectin fragment mediated cartilage chondroly-sis. Osteoarthritis Cartilage 10, 381-393.
14. Homandberg G.A, Wen C, and Hui F. (1998). Cartilage damaging activities of fbronectin fragments derived from cartilage and synovial fuid. Osteoarthritis Cartilage 6, 231-244.
15. Kane L.P, Shapiro V.S, Stokoe D, and Weiss A. (1999). Induction of NF-κB by the Akt/PKB kinase. Curr Biol 9, 601-604.
16. Karin M, Liu Z.G, and Zandi E. (1997). AP-1 function and regulation. Curr Opin Cell Biol 9, 240-246.
17. Kulseth M.A, Kolset S.O, and Ranheim T. (1999) Stimulation of serglycin and CD44 mRNA expression in endothelial cells exposed to TNF-α and IL-1α. Biochim Biophys Acta 1428, 225-232.
18. Li X, Tupper J.C, Bannerman D.D, Winn R.K, Rhodes C.J, and Harlan J.M. (2003) Phosphoinositide 3 kinase mediates Tolllike receptor 4-induced activation of NF-κB in endothelial cells. Infect Immun 71, 4414-4420.
19. Lisignoli G, Grassi F, Zini N, Toneguzzi S, Piacentini A, Guidolin D, Bevilacqua C, and Facchini A. (2001). Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: Evidence for CD44 and CD54 (intercellular adhesion molecule 1) involvement. Arthritis Rheum 44, 1800-1807.
20. Marks-Konczalik J, Chu S.C, and Moss J. (1998). Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor κB-binding sites. J Biol Chem 273, 22201-22208.
21. Marte B.M, and Downward J. (1997). PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 22, 355-358.
22. Mikecz K, Dennis K, Shi M, and Kim J.H. (1999). Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis. Arthritis Rheum 42, 659-668.
23. Moncada S, and Higgs A. (1993). The L-arginine-nitric oxide pathway. N Engl J Med 329, 2002-2012.
24. Müller-Ladner U, Elices M.J, Kriegsmann J.B, Strahl D, Gay R.E, Firestein G.S and Gay S. (1997). Alternatively spliced CS-1 fbronectin isoform and its receptor VLA-4 in rheumatoid arthritis synovium. J Rheumatol 24, 1873-1880.
25. Neidhart M, Gay R.E, and Gay S. (2000) Anti-interleukin-1 and anti-CD44 interventions producing signifcant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 43, 1719-1728.
26. Nishida Y, D'Souza A, Thonar E, and Knudson W. (2000) Stimulation of hyaluronan metabolism by interleukin-1α in human articular cartilage. Arthritis Rheum 43, 1315-1326.
27. Ostergaard K, Salter D.M, Andersen C.B, Petersen J, and Bendtzen K. (1997). CD44 expression is up-regulated in the deep zone of osteoarthritic cartilage from human femoral heads. Histopathology 31, 451-459.
28. Ozes O.N, Mayo L.D, Gustin J.A, Pfeffer S.R, Pfeffer L.M, and Donner D.B. (1999). NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401, 82-85.
29. Parker A.E, Boutell J, Carr A, and Maciewicz R.A. (2002). Novel cartilage-specifc splice variants of fbronectin. Osteoar-thritis Cartilage 10, 528-534.
30. Pulai J.I, Chen H, Im H-J, Kumar S, Hanning C, Hedge P.S, and Loeser R.F. (2005). NF-κB mediates the stimulation of cy-tokine and chemokine expression by human articular chon-drocytes in response to fibronectin fragments. J Immunol 174, 5781-5788.
31. Reddy S.A, Huang J.H, and Liao W.S. (1997). Phosphatidylino-sitol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFκB and AP-1 activation. J Biol Chem 272, 29167-29173.
32. Reddy S.A, Huang J.H, and Liao W.S. (2000). Phosphatidylino-sitol 3-kinase as a mediator of TNF-induced NF-κB activation. J Immunol 164, 1355-1363.
33. Romashokova J.A, and Makarov S.S. (1999). NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401, 86-90.
34. Rutter J.L, Benbow U, Coon C.I, and Brinckerhoff C.E. (1997). Cell-type specific regulation of human interstitial colla-gense-1 gene expression by interleukin-1β (IL-1β) in human fbroblasts and BC-8701 breast cancer cells. J Cell Biochem 66, 322-336.
35. Sakurai H, Kohsaka H, Liu M.F, Higashiyama H, Hirata Y, Kanno K, Saito I, and Miyasaka N. (1995). Nitric oxide production and inducible nitric oxide synthase expression in in-fammatory arthritides. J Clin Invest 96, 2357-2363.
36. Shimizu M, Yasuda T, Nakagawa T, Yamashita E, Julovi S.M, Hiramitsu T, and Nakamura T. (2003). Hyaluronan inhibits matrix metalloproteinase-1 production by rheumatoid synovi-al fibroblasts stimulated by proinflammatory cytokines. J Rheumatol 30, 1164-1172.
37. Sizemore N, Leung S, and Stark G.R. (1999). Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/ RelA subunit. Mol Cell Biol 19, 4798-4805.
38. Takagi T, Okamoto R, Suzuki K, Hayashi T, Sato M, Sato M, Kurosaka N, and Koshino T. (2001). Up-regulation of CD44 in rheumatoid chondrocytes. Scand J Rheumatol 30,110-113.
39. Toba T, Mizusawa N, Tajima G, and Horiuchu S. (1997). Up-regulation of CD44 mRNA expression by interleukin-1β in cultured rabbit articular chondrocytes. J Bone Miner Metab 15, 84-93.
40. Xie DL, Meyers R, and Homandberg G.A. (1992). Fibronectin fragments in osteoarthritic synovial fuid. J Rheumatol 19, 1448-1452.
41. Yasuda T. (2006). Cartilage destruction by matrix degradation products. Mod Rheumatol 16, 197-205.
42. Yasuda T. (2010). Comparison of hyaluronan effects among normal, osteoarthritis, and rheumatoid arthritis cartilages stimulated with fbronectin fragment. Biomed Res 31, 63-69.
43. Yasuda T. (2011). Hyaluronan inhibits Akt leading to nuclear factor-κB down-regulation in lipopolysaccharide-stimulated U937 macrophages. J Pharmacol Sci, 115, 509-515.
44. Yasuda T, Julovi SM, Hiramitsu T, Yoshida M, and Nakamura T. (2004) Requirement of mitogen-activated protein kinase for collagenase production by the fbronectin fragment in human articular chondrocytes in culture. Mod Rheumatol 14, 54-60.
45. Yasuda T, Kakinuma T, Julovi S.M, Yoshida M, Hiramitsu T, Akiyoshi M, and Nakamura T. (2004) COOH-terminal hepa-rin-binding fbronectin fragment induces nitric oxide production in rheumatoid cartilage through CD44. Rheumatology (Oxford) 43, 1116-1120.
46. Yasuda T, and Nakamura T. (2007) Inhibition of nuclear factor-κB by hyaluronan in rheumatoid chondrocytes stimulated with COOH-terminal heparin-binding fbronectin fragment. Mod Rheumatol 17, 391-397.
47. Yasuda T, and Poole A.R. (2002). A fbronectin fragment induces type II collagen degradation by collagenase through an in-terleukin-1-mediated pathway. Arthritis Rheum 46, 138-148.
48. Yasuda T, Poole A.R, Shimizu M, Nakagawa T, Julovi S.M, Tamamura H, Fujii N and Nakamura T, (2003). Involvement of CD44 in induction of matrix metalloproteinases by a COOH-terminal heparin-binding fragment of fbronectin in human articular cartilage in culture. Arthritis Rheum 48, 1271-1280.